BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galderma Laboratories 

14501 N. Freeway

Fort Worth  Texas  76177  U.S.A.
Phone: 817-961-5000 Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Galderma Laboratories Announces Positive Results Of Phase 3 Trials Of Investigational Ivermectin 1% Targeting Papulopustular Rosacea 3/24/2014 7:30:20 AM    More...
Bioventus Acquires DUROLANE® Assets From Galderma 2/4/2014 9:35:19 AM    More...
Galderma Laboratories Slashes U.S. Staff After President's Exit 12/13/2013 8:10:13 AM    More...
Onset Dermatologics (Formerly known as Onset Therapeutics) Acquires Worldwide Rights to Clindagel® (clindamycin phosphate gel) Topical Gel, 1% From Galderma Laboratories 10/31/2013 12:29:49 PM    More...
Galderma Laboratories Serves as Premier Sponsor for 2013 Commit to Cure Gala Benefitting National Psoriasis Foundation 10/21/2013 8:05:34 AM    More...
Galderma Laboratories Release: Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship 9/11/2013 9:27:51 AM    More...
Galderma Laboratories Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea 8/26/2013 6:57:46 AM    More...
New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients 8/1/2013 11:23:11 AM    More...
Galderma Laboratories Release: Epiduo® TAP Program May Increase Patient Adherence to Acne Treatment 3/12/2013 9:36:26 AM    More...
Galderma Laboratories Release: Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available for Children as Young as 9 Years Old 2/20/2013 9:25:00 AM    More...
12345